Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study GroupTimothy R. Rebbeck, Barbara Weber, Susan L. Neuhausen et al.|Journal of Clinical Oncology|2005Cited by 406
Assessing the Risk of Breast CancerKatrina Armstrong, Barbara Weber, Andrea Eisen|New England Journal of Medicine|2000Cited by 320
Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known <i>BRCA1/2</i> MutationsEsmé Finlay, Susan M. Domchek, Jill E. Stopfer et al.|Genetic Testing|2008Cited by 168
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With <i>BRCA1/2</i> Mutations: A Decision AnalysisKatrina Armstrong, Barbara Weber, Thomas C. Randall et al.|Journal of Clinical Oncology|2004Cited by 162